1. Home
  2. LABT vs JWEL Comparison

LABT vs JWEL Comparison

Compare LABT & JWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$2.29

Market Cap

5.3M

Sector

Health Care

ML Signal

N/A

Logo Jowell Global Ltd.

JWEL

Jowell Global Ltd.

HOLD

Current Price

$2.55

Market Cap

5.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LABT
JWEL
Founded
N/A
2012
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
5.7M
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
LABT
JWEL
Price
$2.29
$2.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
191.1K
1.4M
Earning Date
N/A
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$1.47
52 Week High
$6.85
$5.17

Technical Indicators

Market Signals
Indicator
LABT
JWEL
Relative Strength Index (RSI) 43.95 53.12
Support Level $2.07 $1.97
Resistance Level $2.48 $5.17
Average True Range (ATR) 0.21 0.57
MACD 0.03 0.01
Stochastic Oscillator 39.64 31.35

Price Performance

Historical Comparison
LABT
JWEL

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing.

Share on Social Networks: